Disposition of flavonoids via enteric recycling: enzyme-transporter coupling affects metabolism of biochanin A and formononetin and excretion of their phase II conjugates
- PMID: 15128864
- DOI: 10.1124/jpet.104.068403
Disposition of flavonoids via enteric recycling: enzyme-transporter coupling affects metabolism of biochanin A and formononetin and excretion of their phase II conjugates
Abstract
The purpose of this study was to continue our effort to determine how enzyme-transporter coupling affect disposition of flavonoids. The rat intestinal perfusion and Caco-2 cell models were used together with relevant microsomes. In perfusion model, isoflavone (i.e., formononetin and biochanin A) absorption and subsequent excretion of its metabolites were always site-dependent. Maximal amounts of intestinal and biliary conjugates excreted per 30 min were 31 and 51 nmol for formononetin, more than that for pure biochanin A (12 and 20 nmol). When a standardized red clover extract (biochanin A/formononetin = 10:7) was used, the results indicated that more metabolites of biochanin A than formononetin were found in the perfusate (36.9 versus 22.8 nmol) and bile (78 versus 51 nmol). In metabolism studies, rat intestinal and liver microsomes always glucuronidated biochanin A faster (p < 0.05) than formononetin, whereas intestinal microsomes glucuronidated both isoflavones faster (p < 0.05) than liver microsomes. However, rapid metabolism in the microsomes did not translate into more efficient excretion in either the rat perfusion model as shown previously or in the Caco-2 model. In the Caco-2 model, both isoflavones were rapidly absorbed, efficiently conjugated, and the conjugates excreted apically and basolaterally. More formononetin conjugates were excreted than biochanin A when used alone, but much more biochanin A conjugates were found when using the isoflavone mixture. In conclusion, efficiency of enzyme-transporter coupling controls the amounts of metabolites excreted by the intestine and liver and determines the relative contribution of enteric and enterohepatic recycling to the in vivo disposition of isoflavones.
Similar articles
-
Metabolism of flavonoids via enteric recycling: role of intestinal disposition.J Pharmacol Exp Ther. 2003 Mar;304(3):1228-35. doi: 10.1124/jpet.102.046409. J Pharmacol Exp Ther. 2003. PMID: 12604700
-
Disposition of flavonoids via recycling: comparison of intestinal versus hepatic disposition.Drug Metab Dispos. 2005 Dec;33(12):1777-84. doi: 10.1124/dmd.105.003673. Epub 2005 Aug 24. Drug Metab Dispos. 2005. PMID: 16120792
-
Disposition of flavonoids via enteric recycling: structural effects and lack of correlations between in vitro and in situ metabolic properties.Drug Metab Dispos. 2006 Nov;34(11):1837-48. doi: 10.1124/dmd.106.009910. Epub 2006 Aug 1. Drug Metab Dispos. 2006. PMID: 16882763
-
The metabolism and analysis of isoflavones and other dietary polyphenols in foods and biological systems.Food Funct. 2011 May;2(5):235-44. doi: 10.1039/c1fo10025d. Epub 2011 May 9. Food Funct. 2011. PMID: 21779561 Free PMC article. Review.
-
Oxidative metabolism and genotoxic potential of major isoflavone phytoestrogens.J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Sep 25;777(1-2):211-8. doi: 10.1016/s1570-0232(02)00215-5. J Chromatogr B Analyt Technol Biomed Life Sci. 2002. PMID: 12270214 Review.
Cited by
-
The Sex-Gender Effects in the Road to Tailored Botanicals.Nutrients. 2019 Jul 17;11(7):1637. doi: 10.3390/nu11071637. Nutrients. 2019. PMID: 31319627 Free PMC article. Review.
-
Flavonoids and flavonoid-based nanoparticles for the treatment of arthritis.Inflammopharmacology. 2025 May;33(5):2193-2216. doi: 10.1007/s10787-025-01722-0. Epub 2025 Mar 29. Inflammopharmacology. 2025. PMID: 40156677 Review.
-
Breast cancer resistance protein (BCRP) and sulfotransferases contribute significantly to the disposition of genistein in mouse intestine.AAPS J. 2010 Dec;12(4):525-36. doi: 10.1208/s12248-010-9209-x. Epub 2010 Jun 26. AAPS J. 2010. PMID: 20582579 Free PMC article.
-
Glucuronidation: driving factors and their impact on glucuronide disposition.Drug Metab Rev. 2017 May;49(2):105-138. doi: 10.1080/03602532.2017.1293682. Epub 2017 May 22. Drug Metab Rev. 2017. PMID: 28266877 Free PMC article. Review.
-
Novel treatment for refractory rheumatoid arthritis with total glucosides of paeony and nobiletin codelivered in a self-nanoemulsifying drug delivery system.Acta Pharmacol Sin. 2022 Aug;43(8):2094-2108. doi: 10.1038/s41401-021-00801-6. Epub 2021 Dec 6. Acta Pharmacol Sin. 2022. PMID: 34873316 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources